BriaCell Therapeutics Corp.
BCTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001610820
No open-market purchases or sales by BriaCell Therapeutics Corp. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $1.58M in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in BriaCell Therapeutics Corp. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 24
- +14 vs. Q1 2021
- Shares held
- 3.80M
- +3.43M (+913.2%) vs. Q1 2021
- Total value
- $20.3M
- +$18.8M (+1,300.5%) vs. Q1 2021
- New holders
- 16
- 5 more added
- Sold out
- 2
- 2 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BCTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 19 | $1.58M |
| Q1 2026 | 16 | $1.62M |
| Q4 2025 | 13 | $69.2K |
| Q3 2025 | 13 | $136.5K |
| Q2 2025 | 16 | $181.1K |
| Q1 2025 | 14 | $94.1K |
| Q4 2024 | 26 | $379.1K |
| Q3 2024 | 22 | $538.1K |
| Q2 2024 | 20 | $452.0K |
| Q1 2024 | 20 | $6.38M |
| Q4 2023 | 26 | $14.6M |
| Q3 2023 | 21 | $17.0M |
| Q2 2023 | 21 | $17.9M |
| Q1 2023 | 21 | $19.4M |
| Q4 2022 | 21 | $12.3M |
| Q3 2022 | 22 | $14.3M |
| Q2 2022 | 22 | $17.0M |
| Q1 2022 | 18 | $33.5M |
| Q4 2021 | 20 | $10.9M |
| Q3 2021 | 21 | $4.77M |
| Q2 2021 | 24 | $20.3M |
| Q1 2021 | 10 | $1.45M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding BriaCell Therapeutics Corp.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Altium Capital Management LP | 800,295 | $4.27M | 0.99% | +800,295 | New |
| Armistice Capital, LLC | 570,343 | $3.04M | 0.08% | +570,343 | New |
| Kepos Capital LP | 500,000 | $2.67M | 0.20% | +500,000 | New |
| MMCAP International Inc. SPC | 400,000 | $2.13M | 0.19% | +400,000 | New |
| Hudson Bay Capital Management LP | 400,000 | $2.13M | 0.03% | +400,000 | New |
| CVI Holdings, LLC | 320,800 | $1.71M | 0.12% | +320,800 | New |
| Murchinson Ltd. | 250,000 | $1.33M | 0.49% | +250,000 | New |
| Sabby Management, LLC | 196,033 | $1.04M | 0.23% | +35,851+22.4% | Added |
| Redmond Asset Management, LLC | 131,731 | $702.0K | 0.21% | 00.0% | Unchanged |
| Marshall Wace, LLP | 63,226 | $337.0K | 0.00% | +63,226 | New |
| Summit Trail Advisors, LLC | 35,000 | $187.0K | 0.02% | +35,000 | New |
| Bank of America Corp | 22,349 | $119.0K | 0.00% | +22,349 | New |
| Verition Fund Management LLC | 22,311 | $119.0K | 0.00% | +22,311 | New |
| Eqis Capital Management, Inc. | 21,182 | $113.0K | 0.01% | +4,843+29.6% | Added |
| Morgan Stanley | 18,227 | $97.0K | 0.00% | +18,227 | New |
| Two Sigma Advisers, LP | 16,900 | $90.0K | 0.00% | +16,900 | New |
| UBS Group AG | 13,308 | $71.0K | 0.00% | +12,676+2,005.7% | Added |
| Goldman Sachs Group Inc | 11,108 | $59.0K | 0.00% | +11,108 | New |
| Advisory Services Network, LLC | 4,500 | $24.0K | 0.00% | +4,500 | New |
| Tower Research Capital LLC (TRC) | 3,288 | $18.0K | 0.00% | +3,288 | New |
| Toronto Dominion Bank | 842 | $5.00K | 0.00% | +830+6,916.7% | Added |
| Harbour Investments, Inc. | 185 | $1.00K | 0.00% | +20+12.1% | Added |
| Advisor Group Holdings, Inc. | 12 | $0 | 0.00% | −6,000−99.8% | Reduced |
| Royal Bank of Canada | 7 | $0 | 0.00% | −10−58.8% | Reduced |
| Zeke Capital Advisors, LLC | 0 | $0 | 0.00% | −45,000−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −15,121−100.0% | Sold out |